Tremors

Eledon Pharmaceuticals Presents Long-Term Phase 2 BESTOW Data Showing Tegoprubart Benefits Over Tacrolimus in Kidney Transplant

Jun 22, 2026

Eledon Pharmaceuticals reported positive long-term Phase 2 BESTOW trial results for tegoprubart in kidney transplant, showing sustained kidney function benefits and improved patient outcomes versus tacrolimus. The company outlined plans for a Phase 3 registrational trial and seeks an FDA meeting in early 2027. Safety data indicated lower adverse event rates with tegoprubart.

Doctors Implant Dopamine-Producing Stem Cells in Parkinson's Patients in Groundbreaking Trial

Mar 29, 2026

Doctors are implanting lab-grown stem cells into Parkinson's patients' brains in a groundbreaking clinical trial to restore dopamine production. The FDA has granted the Phase 1 REPLACE trial fast-track designation, testing iPSC-derived dopamine-producing cells in 12 patients with moderate to severe Parkinson's. Researchers will monitor participants for up to five years to assess motor function restoration and potential side effects.

T-cell Immunotherapies Show Promise Amid Cardiotoxicity and Operational Challenges

Feb 24, 2026

T-cell immunotherapies including CAR T-cell therapy and T-cell engagers are expanding cancer treatment options but present significant cardiovascular risks and operational complexities requiring coordinated multidisciplinary management.

Brain Implant Detects Parkinson's Patients' Walking States During Daily Activities

Feb 14, 2026

Researchers demonstrate that a fully implanted brain device can detect walking states in Parkinson's patients during unsupervised daily activities, opening the door to adaptive deep brain stimulation therapies that adjust to real-world movement.